Effects of Astragalus and saponins of Panax notoginseng on MMP-9 in patients with type 2 diabetic macroangiopathy / 中国中药杂志
Zhongguo Zhong Yao Za Zhi
; (24): 264-266, 2004.
Article
de Zh
| WPRIM
| ID: wpr-256374
Bibliothèque responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the role and mechanism of Astragalus (AS) and saponins of Panax notoginseng (PNS) in treating type 2 diabetic macroangiopathy.</p><p><b>METHOD</b>94 patients with type 2 diabetic macroangiopathy were divided into two groups randomly: group treated with Simvastatin and group treated with AS and PNS, compared with 40 healthy control subjects. Serum level of MMP-9 and lipid in patients and healthy subjects were measured before and after treatment.</p><p><b>RESULT</b>The serum levels of MMP-9, TG, TC, LDL-C, VLDL-C in patients with type 2 diabetic macroangiopathy were improved, while the levels of HDL-C were decreased. Like Simvastatin AS and PNS had the function of reducing MMP-9 and accommodating lipid metabolism.</p><p><b>CONCLUSION</b>Besides accommodating lipid metabolism, AS and PNS can also reduce the level of serum MMP-9 soas to treat type 2 diabetic macroangiopathy.</p>
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Pharmacologie
/
Plantes médicinales
/
Sang
/
Médicaments issus de plantes chinoises
/
Chimie
/
Simvastatine
/
Matrix metalloproteinase 9
/
Astragalus membranaceus
/
Ginsénosides
/
Utilisations thérapeutiques
Limites du sujet:
Aged
/
Female
/
Humans
/
Male
langue:
Zh
Texte intégral:
Zhongguo Zhong Yao Za Zhi
Année:
2004
Type:
Article